IgG anti SSA 52 KD
The device SSA52.CE is an Enzyme ImmunoAssay (ELISA) intended to be used for the quantitative determination of IgG autoantibodies against SSA-52KD autoantigens in human plasma and sera.
Autoimmunity is the failure of an organism to recognize its own constituent parts as self, which allows an immune response against its own cells and tissues. Any disease that results from such an aberrant immune response is termed an Autoimmune Disease.
Rheumatoid autoimmune diseases are often associated with the occurrence of autoantibodies against several nuclear or cytoplasmatic antigens. We can to distinguish between Anti Nuclear Antibodies (ANA), associate with autoimmune systemic diseases as SLE (Systemic Lupus Erythematosus), RA (Reumatoid Arthritis), Scleroderma, MCDT (Mixed Connective Tissue Disease) and Sjogren’s Syndrome; and Extractable anti Nuclear Antibodies (ENA), associate with Polymyositis, SLE, MCDT and Sjogren’s Syndrome.
Ro/SSA and La/SSB are cytoplasmatic antigens that occur in combination in patients with Sjögren-Syndrome. Autoantibodies against SSA-52 KDa ribonucleoprotein are clinically important since they are associated with subacute cutaneous lupus erythematosus (SCLE) and neonatal lupus erythematosus (NLE).
Anti-Ro/SSA are present in approximately 70% of such patients.
Microplates are coated with a preparation of Recombinant SSA 52KDa antigen. In the 1st incubation, the solid phase is treated with diluted samples and anti-SSA52 IgG are captured, if present, by the solid phase.
After washing out all the other components of the sample, in the 2nd incubation the bound anti-SSA52 IgG are detected by the addition of anti hIgG antibody, labelled with peroxidase (HRP).
The enzyme captured on the solid phase, acting on the substrate/chromogen mixture, generates an optical signal that is proportional to the amount of anti-SSA52 IgG antibodies present in the sample. IgG in the sample may be quantitated by means of a standard curve calibrated in arbitrary units per milliliter (arbU/ml) as no international standard is available.
- Biochem J. 1995 January 15; 305(Pt 2): 359–362.Expression and DNA binding of the human 52 kDa Ro/SSA autoantigen. M B Frank, V R McCubbin, and C Heldermon
- Immunology. 2002 June; 106(2): 246–256 The 52 000 MW Ro/SS-A autoantigen in Sjögren’s syndrome/systemic lupus erythematosus (Ro52) is an interferon- inducible tripartite motif protein associated with membrane proximal structures Davd A Rhodes,* Gudrun Ihrke,* Anna T Reinicke,† Georg Malcherek,† Michael Towey,† David A Isenberg,‡ and John Trowsdale†
- 1994: Frank M B; Itoh K; McCubbin V Epitope mapping of the 52-kD Ro/SSA autoantigen. Clinical and experimental immunology 1994;95(3):390-6.
- (Clinical Chemistry. 2005;51:2426-2427.) Antibodies to Extractable Nuclear Antigens in Antinuclear Antibody–Negative Samples Xavier Bossuyta and Ariane Luyckx Laboratory Medicine, Immunology, University Hospital Leuven, Leuven, Belgium